Rivoceranib Plus Paclitaxel in Patients With Gastrointestinal Stromal Tumor

Condition:   Gastrointestinal Stromal Tumors Intervention:   Drug: Rivoceranib Mesylate, Paclitaxel Sponsor:   Asan Medical Center Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials